The Quick Answer
GLP-1 medications like Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide), and Zepbound can improve fertility in women with obesity or PCOS by restoring ovulation — sometimes within weeks. They may also reduce oral contraceptive effectiveness by delaying gastric emptying. However, GLP-1 drugs should be stopped before attempting pregnancy, typically 2-3 months prior. They are not approved fertility treatments, and long-term safety data in pregnancy is limited.
"It's not an overstatement to say we're seeing an Ozempic baby boom," says Dr. Deidre McIntosh, OB-GYN at Cleveland Clinic. And the data backs her up: reproductive endocrinologists across the country are reporting that patients on GLP-1 medications are conceiving — some after years of unsuccessful trying, and some by complete surprise.
The #OzempicBabies hashtag has gone viral on TikTok. NPR aired a segment on "The Future of Fertility in 2026" that led with the GLP-1 connection. Fertility clinics are now routinely asking new patients about GLP-1 use during intake. This is no longer a fringe phenomenon — it's reshaping how doctors think about metabolic health and reproduction.
But between the breathless social media posts and the cautious clinical guidelines, there's a lot of confusion. Let's sort through what we actually know.
How GLP-1 Drugs Affect Fertility
GLP-1 receptor agonists work primarily by mimicking a gut hormone that regulates blood sugar, appetite, and gastric emptying. They were developed for type 2 diabetes and later approved for weight management. Nobody designed them to be fertility drugs. But the metabolic changes they trigger can have profound reproductive consequences — in both directions.
The Fertility-Boosting Mechanism
For women with obesity-related anovulation or PCOS with insulin resistance, GLP-1 drugs can restore ovulation through several pathways:
- Insulin sensitivity: By dramatically improving insulin resistance, GLP-1s reduce the hyperinsulinemia that drives excess androgen production in PCOS. Lower androgens = more regular ovulatory cycles.
- Weight loss: Even modest weight loss (5-10% of body weight) can restore ovulation in women with obesity-related infertility. GLP-1s facilitate this far more effectively than lifestyle changes alone.
- Direct metabolic effects: Some evidence suggests ovulation can resume within 6-12 weeks of starting a GLP-1 drug — before significant weight loss has occurred. This implies a direct metabolic effect, not just a weight-mediated one.
- Reduced inflammation: Chronic low-grade inflammation impairs egg quality and implantation. GLP-1s have anti-inflammatory properties that may improve the reproductive environment.
What Clinicians Are Seeing
Reproductive endocrinologists are increasingly prescribing semaglutide as preconception preparation for obese patients planning IVF, citing evidence that pre-retrieval weight loss significantly improves egg quality and implantation rates. Some are using it as a first-line intervention for PCOS patients who failed to ovulate on clomiphene or letrozole alone.
The critical clinical point: ovulation can resume within weeks of starting a GLP-1 drug. A woman who has been anovulatory for years may become ovulatory while still clinically obese. This catches many patients off guard.
The Contraceptive Interference Problem
The other side of the coin is equally important: GLP-1 drugs can reduce the effectiveness of oral birth control pills. Here's why: these medications delay gastric emptying — food and pills sit in the stomach longer. This can interfere with how oral contraceptives are absorbed, potentially reducing their effectiveness. The FDA issued a label update addressing this interaction in 2023.
This means women on GLP-1s who are relying on the pill for contraception may become pregnant unintentionally — the "Ozempic babies" that social media is buzzing about. If you're on a GLP-1 drug and don't want to become pregnant, talk to your doctor about non-oral contraceptive methods (IUD, implant, etc.).
Who Might Benefit From GLP-1s Before TTC
Based on current evidence and clinical practice, GLP-1 medications may support fertility in specific populations:
- Women with BMI 30+ and anovulation: When excess weight is preventing ovulation and lifestyle changes haven't been sufficient
- PCOS with insulin resistance: Particularly when metformin hasn't worked or isn't tolerated
- Pre-IVF preparation: When a reproductive endocrinologist recommends weight optimization before egg retrieval
- Metabolic syndrome affecting fertility: High insulin, elevated androgens, irregular cycles driven by metabolic dysfunction
GLP-1s are not appropriate for women at a healthy weight who are looking for a fertility boost, for women who are already pregnant, or as a replacement for standard fertility treatments when metabolic health isn't the primary issue.
The Critical Timeline: When to Stop
This is the part that gets missed in the social media conversation: GLP-1 drugs should be stopped well before pregnancy. Most reproductive endocrinologists recommend a washout period of 2-3 months before attempting conception.
- During fertility evaluation and genetic testing: You can typically continue GLP-1s
- When IVF stimulation begins: Stop approximately 2 weeks before egg retrieval (anesthesia risk due to delayed gastric emptying)
- If freezing embryos for PGT: Shorter washout may be acceptable since pregnancy isn't immediate
- Before embryo transfer or natural TTC: At least 8 weeks (ideally 2-3 months) before conception to allow full clearance
The reason: animal studies have raised concerns about GLP-1 exposure during early pregnancy. While human data is limited, the precautionary principle applies. No fertility specialist will recommend continuing these drugs during pregnancy.
The Bigger Picture: GLP-1s and the Future of Fertility Medicine
What makes the Ozempic Baby Boom significant isn't just the individual pregnancies — it's what it reveals about the relationship between metabolic health and fertility. For decades, the fertility industry has focused primarily on hormonal interventions (clomiphene, letrozole, gonadotropins) and procedures (IUI, IVF). The GLP-1 revolution suggests that fixing the metabolic environment first may make those interventions work better — or unnecessary in some cases.
This is still early. We need large-scale, controlled fertility studies of GLP-1s (not just anecdotal reports and small observational data). But the clinical trajectory is clear: metabolic optimization is becoming a standard part of the preconception toolkit, and GLP-1s are the most powerful metabolic tools we've ever had.
Supporting Your Metabolic Health Naturally
Whether or not you're on a GLP-1 medication, supplements like berberine (which activates similar GLP-1 pathways naturally), inositol (for insulin sensitivity in PCOS), and magnesium (for blood sugar support) can complement your metabolic health strategy.
Browse Metabolic Support Supplements →Explore This Topic Across Our Sites
Frequently Asked Questions
Can I get pregnant while taking Ozempic?
Yes — it's biologically possible and is happening frequently enough to earn the term "Ozempic babies." GLP-1 drugs can restore ovulation in women who weren't ovulating, and they may reduce oral birth control effectiveness. If you don't want to become pregnant, use a non-oral contraceptive method while on GLP-1 medications.
Is it safe to take Ozempic during pregnancy?
No — GLP-1 medications are not recommended during pregnancy. Animal studies have raised concerns, and there isn't enough human safety data. Most specialists recommend stopping GLP-1 drugs 2-3 months before trying to conceive to allow full clearance from the body.
Can Ozempic help with IVF success?
Emerging evidence suggests that using GLP-1 drugs for weight optimization before IVF may improve egg quality and implantation rates. Some reproductive endocrinologists are prescribing semaglutide as preconception preparation for obese patients planning IVF. However, the medication must be stopped before stimulation begins.
Is berberine really "nature's Ozempic"?
Berberine does activate some of the same GLP-1 pathways, but its effects are significantly milder. It may help with blood sugar regulation, insulin sensitivity, and modest appetite changes — but it won't produce the dramatic weight loss or metabolic reset of pharmaceutical GLP-1 drugs. It's a supplement, not a drug equivalent.
Does Ozempic affect male fertility?
Early evidence is mixed. Some anecdotal reports suggest improved fertility in male partners who lost significant weight on GLP-1s (weight loss generally improves testosterone and sperm quality). But there's limited data on direct effects on sperm. If your partner is on a GLP-1 drug and you're TTC, discuss the timeline with his prescriber.